12-08-2026 17:53 via drugs.com

AMH Predicts Benefit of Chemo + Endocrine Therapy in Under 55s With Breast Cancer

WEDNESDAY, Aug. 12, 2026-- Anti-Müllerian hormone (AMH) appears to predict the benefit of chemotherapy plus endocrine therapy (CET) versus ET alone in premenopausal women younger than 55 years with hormone receptor-positive/human epidermal growth...
Read more »

Pharmaceutical Industry news



Huge Gap Exists Between Regulatory Authorization, Clinical Validation of AI Medical Devices
December 2024 to 2025 Saw Significant Increase in Leucovorin Dispensing
Higher Diet Quality Linked to Improved Lung Function in Asthma, COPD
Habitual Fasting May Be Harmful for Older Adults
Small Change in Hours Benefits Emergency Physicians Working Night Shifts
Cannabis Use Linked to Earlier Age of Psychosis Onset
Preoperative Chemo + Immunotherapy Combo Shrinks Head, Neck Cancer Tumors
Aircrew Face Higher Odds of Radiation-Related Cancer Deaths
More Than 2 in 3 Patients View Test Results Before Their Doctor
FDA Authorizes First Standalone Robotic Device to Draw Blood
Composite Dietary Antioxidant Index Inversely Linked to Cervical Cancer Prevalence
Number of Health Care Workers Has Increased 198.5 Percent Since 1990
Childhood-Onset Epilepsy Tied to Lower Rate of Educational Attainment
ED Boarding Time Varies Considerably Across Hospitals
Desktop versie